MK

Mandapati Kavitha

Active Director Designated Partner DIN 07895245
DIN 07895245 First appointment Sep 2017 Primary industry Travel and Hospitality
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Mandapati Kavitha

Data last updated:

Mandapati Kavitha is a Designated Partner at Endocrine Associates Of Hyderabad Llp (since 2017). The company operates in Travel and Hospitality.

DIN 07895245
Primary Designation Designated Partner
Industry Travel and Hospitality
First Appointment 09 Sep 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Sep 20172017Active

Board colleagues of Mandapati Kavitha

NameDINCompanyDesignation
Chanukya Veera Griddaluru07895253Endocrine Associates Of Hyderabad LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Endocrine Associates Of Hyderabad Llp
Premium access

Shareholding and investment profile for Mandapati Kavitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mandapati Kavitha

Mandapati Kavitha currently holds 1 directorship: Endocrine Associates Of Hyderabad Llp (Designated Partner, since 09 Sep 2017).

Mandapati Kavitha was first appointed on 09 Sep 2017 as Designated Partner at Endocrine Associates Of Hyderabad Llp.

The current boards of Mandapati Kavitha's companies include Chanukya Veera Griddaluru (Endocrine Associates Of Hyderabad Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available